2023 annual financial data
TransCode Therapeutics 2023 Financial results
Direct answer
Revenue was 0 USD.
Operating income was -19,418,516 USD and net income was -18,546,095 USD.
Operating cash flow was -18,074,535 USD.
Get free TransCode Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -19,418,516 USD
- Net income
- -18,546,095 USD
- Operating cash flow
- -18,074,535 USD
Explore related company data
View all 2023 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all TransCode Therapeutics financial years